EGFR Positive Non-small Cell Lung Cancer
Showing NaN - NaN of 2
EGFR Positive NSCLC Trial in China (APG-1252, Osimertinib Mesylate Tablets)
Recruiting
- EGFR Positive Non-small Cell Lung Cancer
- APG-1252
- Osimertinib Mesylate Tablets
-
Guangzhou, Guangdong, China
- +3 more
Oct 27, 2021
EGFR Positive NSCLC, Adenocarcinoma Trial in China (Sequential Icotinib Plus Chemotherapy, Icotinib)
Unknown status
- EGFR Positive Non-small Cell Lung Cancer
- Adenocarcinoma
- Sequential Icotinib Plus Chemotherapy
- Icotinib
-
Lanzhou, Gansu, China
- +30 more
Apr 27, 2015